- Report
- September 2024
- 23 Pages
Chile
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 27 Pages
Japan
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 24 Pages
Vietnam
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 20 Pages
Algeria
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 30 Pages
United States
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 22 Pages
Azerbaijan
From €995EUR$1,173USD£882GBP
- Report
- September 2024
- 74 Pages
China
From €1636EUR$1,800USD£1,401GBP
- Report
- September 2024
- 103 Pages
China
From €1636EUR$1,800USD£1,401GBP
- Report
- July 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- July 2023
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- January 2022
- 39 Pages
United States
From €995EUR$1,095USD£852GBP
- Report
- October 2021
- 22 Pages
Belarus
From €825EUR$972USD£731GBP
- Report
- September 2021
- 25 Pages
Russia
From €825EUR$972USD£731GBP
- Report
- July 2024
- 280 Pages
Global
From €1689EUR$1,859USD£1,446GBP
€2413EUR$2,655USD£2,066GBP
- Report
- April 2024
- 280 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more